RHOT1 and type 2 diabetes mellitus: It is noteworthy that Miro1 is also decreased in pancreatic cells of patients with type 2 diabetes, with a mouse model of islet Miro1 ablation developing insulin resistance, increased production of ROS, inflammation and dysregulated mitophagy (44).